TABLE 5.
Study | TF | PF | Total |
---|---|---|---|
Brix et al, 20145 | 11/51 (21.6) | 1/2 (50.0) | 12/53 (22.6) |
Ebert et al, 201711 | 2/31 (3.2) | — | 2/31 (3.2) |
Ebert et al, 201212 | 5/63 (7.9) | — | 5/63 (7.9) |
Filardo et al 201414 | — | 0/49 (0.0) | 0/49 (0.0) |
Filardo et al, 201415 | NR | NR | 14/131 (10.7) |
Kon et al, 201619 | — | 4/32 (12.5) | 4/32 (12.5) |
Meyerkort et al, 201423 | — | 0/23 (0.0) | 0/23 (0.0) |
Total | 18/145 (12.4) | 5/106 (4.7) | 37/382 (9.7) |
aFailures are reported as number of failures/total number of patients (%). NR, not reported; PF, patellofemoral; TF, tibiofemoral.